Add Yahoo as a preferred source to see more of our stories on Google. The epinephrine nasal spray is now approved for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult ...

By Hugo Francisco de Souza A novel nasal booster approach may help close the gap between systemic vaccination and infection-blocking mucosal immunity, offering fresh insight into next-generation COVID ...

This new study promisingly reveals nasal vaccines not only induce effective IgA responses but may promote broad immunity against more than just the single viral strain in a vaccine. The study reports ...

Please provide your email address to receive an email when new articles are posted on . Intranasal epinephrine produced pharmacodynamic results that were comparable with or higher than autoinjectors ...

Please provide your email address to receive an email when new articles are posted on . Intranasal spray had faster and higher maximum concentrations than autoinjectors and manual syringes. The spray ...

Lidocaine, when administered via nose drops or a nasal spray, travels through the trigeminal nerve and collects in high concentrations in the teeth, jaw, and structures of the mouth, researchers from ...

Early in the pandemic, when people with COVID-19 began reporting that they lost their sense of smell, Zara Patel, MD, figured as much. A professor of otolaryngology at Stanford Medicine, Patel has, ...

In a study headed by researchers at the Institute of Virology and Immunology (IVI) in Mittelhäusern, a new, two-step flu vaccination strategy that pairs intramuscular injection of a viral vectored flu ...

Aug. 9 (UPI) --The U.S. Food and Drug Administration on Friday announced the approval of the first nasal spray for treatment of anaphylaxis, a life-threatening allergic reaction. The epinephrine nasal ...